Peptide release on the ribosome is catalyzed in the large subunit peptidyl transferase center by release factors on recognition of stop codons in the small subunit decoding center. Here we examine the role of the decoding center in this process. Mutation of decoding center nucleotides or removal of 2 0 OH groups from the codon-deleterious in the related process of tRNA selection-has only mild effects on peptide release. The miscoding antibiotic paromomycin, which binds the decoding center and promotes the critical steps of tRNA selection, instead dramatically inhibits peptide release. Differences in the kinetic mechanism of paromomycin inhibition on stop and sense codons, paired with correlated structural changes monitored by chemical footprinting, suggest that recognition of stop codons by release factors induces specific structural rearrangements in the small subunit decoding center. We propose that, like other steps in translation, the specificity of peptide release is achieved through an induced-fit mechanism.
INTRODUCTION
Translation termination occurs when one of three nearuniversal stop codons is encountered in the A site of the small ribosomal subunit. Stop codons are recognized by class I release factor proteins (RFs), which bind to the ribosome and promote hydrolysis of the completed polypeptide from the P site tRNA. In bacteria, the three stop codons are decoded by two class I RFs with overlapping specificity: RF1 recognizes UAG and UAA while RF2 recognizes UAA and UGA. RF-catalyzed peptide release is efficiently prevented during elongation, leading to an estimated frequency of inaccurate termination at sense codons in vivo of at most 10 À5 for both RF1 and RF2 (Jorgensen et al., 1993) , and discrimination against individual sense codons in vitro ranging from 10 3 -to over 10 6 -fold (Freistroffer et al., 2000) . This level of specificity is at least as great as that achieved during EF-Tu-facilitated tRNA selection (reviewed in Rodnina and Wintermeyer, 2001) , and in this case accuracy is not achieved through a kinetic proofreading mechanism because GTP hydrolysis-associated steps in termination occur downstream of the committed peptide release step (Freistroffer et al., 1997 (Freistroffer et al., , 2000 . The accuracy of peptide release arises from the ability of RFs to promote hydrolysis in the large ribosomal subunit active site specifically at stop codons, which depends ultimately on discrimination between sense and nonsense codons by RFs in the distantly located decoding center of the small subunit. Little is known about the mechanism by which this discrimination is accomplished. In contrast, the equivalent discriminatory step during translation elongation, whereby cognate tRNAs are distinguished from near-cognate tRNAs, has been carefully dissected in a body of recent structural and kinetic studies (Ogle and Ramakrishnan, 2005; Rodnina and Wintermeyer, 2001) . Structurally, specific interactions with the three-nucleotide codon:anticodon helix stabilize conformations of decoding center nucleotides that are not favored in the absence of bound tRNA: G530 rotates from a syn-to an anti-conformation, and A1492 and A1493, which normally stack inside 16S rRNA helix 44 (h44), move to extrahelical positions (Ogle et al., 2001 ) ( Figure 1A ). More global conformational changes in the small subunit collectively referred to as ''domain closure'' are also observed only in the presence of a cognate codon:anticodon interaction (Ogle et al., 2002) . Consistent with these structural observations, mutation of A1492, A1493, or G530 leads to kinetic deficiencies in forward steps in the tRNA selection pathway that can be attributed to defects in closure (Cochella et al., 2007) . The functional relevance of these structural changes is further supported by the fact that miscoding antibiotics, which impact the kinetics of multiple steps in the tRNA selection pathway (Gromadski and Rodnina, 2004b; Pape et al., 2000) , promote these same structural rearrangements even in the absence of bound tRNA . The accuracy of tRNA selection can thus be attributed to ribosome recognition of the geometry of a correct substrate-a codon:anticodon helix with Watson-Crick geometry-leading to acceptance of this substrate via a kinetically driven process described by Rodnina and colleagues (Gromadski and Rodnina, 2004a) .
The molecular mechanisms that determine high accuracy recognition of stop codons are not known. Although an RF ''tripeptide anticodon'' at least partially responsible for the observed codon specificities of RF1 and RF2 has been genetically identified Mora et al., 2003) , mutations outside of this region also affect specificity (Ito et al., 1998; Uno et al., 2002) . Given that RFs have low affinity for stop codon-containing RNAs in solution (Brown and Tate, 1994; Chavatte et al., 2003) , it seems clear that the recognition event must include interactions with the ribosomal environment in which the codon is presented (i.e., the small subunit decoding center). Low-resolution cryo-EM and medium-resolution crystal structures of ribosome-bound RFs (Klaholz et al., 2003; Petry et al., 2005; Rawat et al., 2003) confirm predictions from biochemical and genetic studies that RFs have distinct domains that interact with the peptidyl transferase center on one hand and the decoding center on the other Scarlett et al., 2003; Wilson et al., 2000) , but no detailed structural view of the interactions between RFs and stop codons is available. Kinetically, much of what is known about the accuracy of peptide release comes from biochemical studies by Ehrenberg and colleagues (Freistroffer et al., 2000) , who demonstrated that RF discrimination against the group of sense codons that differ from stop codons by a single nucleotide (''near-stop'') derives both from reductions in the catalytic rate constant (k cat ) and from increases in the concentration of release factor required to achieve half of k cat (K 1/2 ). Although differences in the affinity of RFs for stop-and near-stop-programmed ribosome complexes are expected, the mechanistic underpinning of the observed difference in catalytic rate constant on stop and near-stop codons is not clear. Are release factors bound at nearstop codons simply positioned inappropriately for catalysis, or does the increased k cat on stop codons reflect a specific induction of catalysis on stop codon recognition?
Given that tRNAs and release factors must engage the same two functional centers on the ribosome-the decoding and the peptidyl transferase centers-core strategies for controlling ribosome activity might be shared. Our initial study indicated that, in fact, tRNA selection and stop codon recognition rely on different properties of the ribosomal decoding center ). Here we showing A1492 and A1493 in their intrahelical h44 positions in the absence of bound substrate (left) and in their ''induced'' positions in the presence of bound mRNA and a cognate tRNA anticodon stem-loop (ASL) (center), or in the presence of paromomycin and streptomycin (right). Figure was made using PDB entries 1FJF, 1IBM, and 1FJG Ogle et al., 2001; Wimberly et al., 2000) and PyMOL (http://pymol.sourceforge.net). (B-E) Rate constants for catalysis at saturating release factor concentrations (k cat ) for wildtype and mutant ribosomes on (B) stop-or (C-E) near-stop-programmed ribosomes. Bars represent the mean ± standard error from at least two experiments measured at the following concentrations of RF1: 5 mM for UAG, 125 mM for CAG, 100 mM for UCG, and 200 mM for UAC. Throughout the figures, black bars represent release reactions on stop codons while gray bars indicate reactions on near-stop codons.
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fully examine the effects of mutations in decoding center rRNA and mRNA elements and of miscoding aminoglycoside antibiotics on RF-mediated stop codon recognition. Our results indicate that RF recognition of stop codons induces structural rearrangements in the decoding center that likely explain the observed differences in rates of catalysis of peptide release on stop and near-stop codons. Thus, although the specific structural changes involved are distinct, the specificity of peptide release-like the specificity of tRNA selection-is achieved through an induced-fit mechanism.
RESULTS

Decoding Site Perturbations Have Mild Effects on Peptide Release
To examine the role of the decoding center in peptide release, mutations were incorporated into 16S rRNA nucleotides A1492, A1493, and G530, which play essential roles in tRNA selection (Cochella et al., 2007) . Mutation at these three positions results in dominant lethality (Cochella et al., 2007) , and so variant ribosomes were inducibly expressed and purified using a previously described affinity tagging approach (Youngman and Green, 2005) . A pre-steadystate, single-turnover kinetic assay was used to measure the rate of hydrolysis of f-[ 35 S]-Met from P site-bound f-[
35 S]-Met-tRNA fMet on ribosomes programmed with an mRNA encoding methionine followed by a stop codon (Youngman et al., 2004) . At a saturating RF1 concentration (5 mM), the decoding center nucleotide substitutions had no discernible effect on the rate of peptide release on the stop codon UAG ( Figure 1B) . Some of these mutations do appear to have mild effects on release factor binding as we have reported previously .
We next looked at the effect of these mutations on peptide release at near-stop codons. Initiation complexes were formed on mRNAs that encoded Met followed by CAG, UCG, or UAC, and rate constants for peptide release were measured as above. For each message, RF titrations were performed to establish conditions where the ribosomes (wild-type and variant) were saturated with RF (data not shown). In these reactions on near-stop codons, variant ribosomes now all exhibited substantial defects in catalysis ( Figures 1C-1E ). These defects range from as little as 2.5-fold in the case of the G530A mutant on a UAC codon to as much as 115-fold in the case of the A1493C mutant on UCG. Hence although decoding center mutations had no effect on the rate of peptide release on stop codons, peptide release catalyzed by these same variant ribosomes on near-stop codons is characterized by decreases in the rate constant for peptide release (k cat ).
In an effort to perturb the decoding center in a different manner, we examined the effect of substituting the nucleotides of the A site codon with deoxyribose nucleotides. The decoding site nucleotides make four hydrogen-bonding interactions with 2 0 OH groups on the A site codon during tRNA selection (Ogle et al., 2001 ). On ribosomes carrying DNA in the A site, the loss of these stabilizing interactions between decoding site nucleotides and 2 0 OHs of the A site codon leads to a 10-fold reduction in the affinity of aminoacyl-tRNA (Fahlman et al., 2006; Potapov et al., 1995) and is thought to be responsible for failure to translate a DNA-based message (McCarthy and Holland, 1965) . However, the magnitude of the defects in individual steps of tRNA selection had not been measured. Here, we measure one of these steps, the rate of peptide bond formation between f-[
35 S]-Met-tRNA fMet and PhetRNA Phe on ribosomes programmed with a message containing either an all-ribose or all-deoxyribose Phe codon in the A site. Consistent with the known importance of interactions with the codon:anticodon helix in promoting this reaction, we observed a 60,000-fold decrease in the rate constant at saturation on ribosomes carrying the all-deoxyribose Phe codon in the A site ( Figure 2A ). In contrast, Molecular Cell the k cat for peptide release on ribosomes programmed with a message bearing an all-deoxyribose UAA stop codon was only marginally reduced relative to the all-ribose message (1.4-fold, Figure 2B ), although slightly higher concentrations of RF1 (10 mM) were required to reach saturation. Peptide release is therefore generally refractory to changes in the decoding center relative to the larger effects of these substitutions on tRNA selection.
Effects of Aminoglycoside Antibiotics on Peptide Release
The aminoglycoside antibiotics paromomycin and streptomycin bind to the ribosome in the small subunit decoding center and lead to structural rearrangements that ultimately affect the kinetics of tRNA selection and thus decrease overall accuracy. It has been reported that aminoglycoside antibiotics of the neomycin class inhibit both RF1-and RF2-catalyzed peptide release at stop codons (Brown et al., 1993) and we have observed paromomycin-mediated inhibition of RF1-catalyzed peptide release at stop codons under conditions of low RF concentration . To examine the effect of miscoding agents on the accuracy of peptide release, we prebound streptomycin (20 mM) or paromomycin (5 or 50 mM) to ribosomes programmed with the stop codon UAA or its near-stop neighbors CAA, UCA, or UAC and measured rate constants for peptide release. In initial experiments with each codon, the experiment was performed at a concentration of RF1 known to be saturating in the absence of antibiotic (53 the K 1/2, Freistroffer et al., 2000) . Addition of 20 mM streptomycin had little effect on the rate of peptide release on any of these codons ( Figure 3A ). In contrast, paromomycin dramatically inhibited peptide release at all four codons. In this initial experiment, strong inhibition of peptide release was seen at 5 mM paromomycin for the near-stop codons but required 50 mM paromomycin for the stop codon ( Figure 3B ). This striking difference in responsiveness to paromomycin led us to postulate that RFs might interact with stop and near-stop codons in fundamentally different ways. To examine this possibility, we characterized the kinetic mechanism of paromomycin inhibition. This analysis revealed a number of critical differences in the signature of paromomycin inhibition on stop and near-stop codons that are described in the next section. One intriguing possibility suggested by our results was that paromomycin functioned in the decoding center independently of the RF to modulate catalytic activity in the physically remote peptidyl transferase center. This idea was dismissed after finding that neither the background rate of peptidyl-tRNA hydrolysis nor the rate of peptidyl transfer between f-[
35 S]-Met-tRNA fMet and the A site substrate puromycin was affected by the presence of paromomycin (data not shown).
Paromomycin Inhibits Peptide Release Differently on Stop and Near-Stop Codons
The decrease in the observed rate constant for peptide release in the presence of paromomycin could be due either to a decrease in the affinity of RF1 for paromomycinbound ribosomes or to inhibition of catalysis of peptide release. To distinguish between these possibilities, we measured the observed rate constant for peptide release at increasing concentrations of RF1 and fit the resulting k obs versus [RF1] curves to a hyperbolic equation to determine k cat and K 1/2 . The values for these constants obtained in the absence and presence of the antibiotic were then compared. In the case of peptide release on the stop codon UAA, the inhibitory effect of paromomycin could be attributed entirely to an increase in the K 1/2 of RF1 in the presence of paromomycin. Reciprocal titrations of release factor and paromomycin revealed that paromomycin and RF1 behave competitively on stop codon complexes: the K 1/2 of RF1 increased with increasing paromomycin concentration and the IC 50 of paromomycin increased with increasing RF1 concentration (Figures 4A and 4B) . In contrast, addition of up to 150 mM paromomycin had no effect on k cat (i.e., with saturating RF1, Figure 4C) . Observed rate constants for peptide release on the stop codon UAA or three near-stop codons in the absence or presence of (A) streptomycin or (B) paromomycin. In every case, rate constants were measured at 53 the K 1/2 of RF1 in the absence of antibiotic (Freistroffer et al., 2000) . Those concentrations are as follows: 40 nM for UAA, 100 mM for CAA, and 50 mM for UCA and UAC. Streptomycin was present at 20 mM. Paromomycin was used at 50 mM for UAA and 5 mM for all other codons. Bars represent the mean ± standard error from at least two experiments.
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The paromomycin inhibition data are markedly different for the case of the near-stop-codon complexes where the compound has striking effects on both the RF1 K 1/2 and on k cat . For the two codons where K 1/2 and k cat could be accurately determined both in the absence and presence of paromomycin (UCA and UAC), the magnitude of these effects was similar: K 1/2 was increased by 5-to 10-fold, while k cat was decreased by about 30-fold ( Figures 4D  and 4E ). Paromomycin also clearly decreased k cat on the near-stop codon CAA (from 3.7 3 10 À3 s À1 to less than 1 3 10 À4 s À1 ), although we were not able to accurately determine K 1/2 on this codon due to the very slow rate constants and the high concentrations of RF1 required in the presence of paromomycin. These paromomycin inhibition data for near-stop codon ribosome complexes are thus distinct from what we observed on stop codon complexes, and are not indicative of simple competitive binding.
Synthetic Effects on RF Function Are Observed when Decoding Center Mutations Are Challenged with Paromomycin
We next examined the combined effects of mutations in the decoding center and the presence of paromomycin.
In general, the defects associated with paromomycin addition and mutation of the decoding center appear to be additive. In release reactions on the near-stop codon UCG using A1492G or A1493C mutant ribosomes, addition of 5 mM paromomycin reduced the observed rate constant for peptide release to the point that an accurate rate constant could not be determined (data not shown). A quantitative evaluation of the effect of paromomycin addition to mutant ribosomes could therefore only be performed on ribosomes programmed with a stop codon (UAG), and those results are presented below. In the case of A1492G variant ribosomes, addition of 25 mM paromomycin caused essentially no change in the rate constant for peptide release at a saturating RF1 concentration ( Figure 5A ) but resulted in a large (200-fold) increase in K 1/2 ( Figure 5B ). On A1493C mutant ribosomes, however, the addition of paromomycin resulted in defects in k cat even on this stop codon, whereas the mutation alone had no effect on k cat ( Figure 1B ). In this case, k cat was reduced by nearly 10-fold ( Figure 5A ), and the RF1 K 1/2 was again dramatically increased by about 300-fold ( Figure 5B ). Although the error associated with the measurement of the high K 1/2 values seen in the presence of paromomycin is large, it is clear that paromomycin increases the RF1 K 1/2 for these mutants by at least two orders of magnitude. In all cases, therefore, paromomycin potentiates the defects of decoding site mutants in peptide release.
Release Factor Binding Displaces Bound Paromomycin on Stop, but Not Near-Stop, Codons As discussed above, although paromomycin inhibits peptide release on both stop and near-stop codons, the kinetic mechanism of this inhibition is strikingly different. On stop codon-programmed ribosomes, the simplest explanation for the observed inhibition is that paromomycin acts as a competitive inhibitor of RF binding. This predicts that at the kinetically defined saturating concentration of RF for a given concentration of paromomycin (where k cat is unaffected), paromomycin is not bound to the decoding center. To directly assess this possibility, we used chemical footprinting analysis to ask whether paromomycin binding was affected by the presence of release factor. This assay takes advantage of the known protection of 16S rRNA nucleotide A1408 from DMS by bound paromomycin. Ribosome complexes were formed containing tRNA fMet in the P site of ribosomes programmed with a Met-UAA mRNA. Chemical modification with DMS followed by primer extension analysis resulted in a strong primer extension stop at position A1408 ( Figure 6A ). Addition of paromomycin to these same complexes resulted in strong protection from DMS modification at A1408 as previously described (Moazed and Noller, 1987) . Importantly, addition of RF1 alone to these complexes resulted in discernible but modest protection at this position ( Figures 6A  and 6B ). When paromomycin was prebound to these ribosome complexes and RF1 then added prior to modification with DMS, paromomycin protection at A1408 was lost in an RF1-concentration-dependent manner (see quantitation in Figure 6C ). Given that paromomycin makes direct contacts with A1408 when bound to the ribosome (Ogle et al., 2001) , the observed loss of protection likely reflects paromomycin dissociation. These results are consistent with mutually exclusive binding of paromomycin and RF1 to stop codon-programmed ribosomes. On near-stop codons, paromomycin inhibition of peptide release results from both a decrease in k cat and an increase in the K 1/2 for RF1. The effects of paromomycin on k cat even under conditions of saturating RF suggest that these two agents can bind simultaneously to near-stopprogrammed ribosomes. We again used DMS footprinting to assess the state of paromomycin binding to ribosomes programmed with the near-stop codon UCA in the absence and presence of RF1. As on stop codon-programmed ribosomes, paromomycin binding protects A1408 from modification. In this case, however, addition of RF1 to complexes containing paromomycin caused little to no change in the protection of A1408 (Figures 6B and  6C ). These data indicate that, in contrast to stop codonprogrammed ribosomes, paromomycin remains bound even at saturating RF1 concentrations when ribosomes are programmed with a near-stop codon.
DISCUSSION
This quantitative analysis of the effects of decoding center mutations and aminoglycoside antibiotics on peptide release provides insights into the mechanism of stop codon recognition by release factors. The most immediate conclusion that emerges from our data is that the mechanism by which stop codons are recognized on the ribosome must be quite different than that by which cognate aminoacyl-tRNAs are recognized. Mutation of conserved decoding center nucleotides, demonstrated to cause substantial defects (10-to 50-fold) in the forward rates associated with tRNA selection (Cochella et al., 2007) , in contrast has very little effect on peptide release at stop codons (Figure 1) . Similarly, removal of 2 0 OH groups from the A site codon leads to a dramatic (60,000-fold) reduction in the rate of accommodation of cognate aminoacyl-tRNA but has almost no effect on peptide release (Figure 2) . Finally, two miscoding antibiotics that bind in or near the decoding center have distinct effects on the processes of tRNA selection and peptide release. Paromomycin, which generally promotes the steps of tRNA selection, instead acts as a competitive inhibitor of RF binding on stop codons and thus negatively affects RF-mediated stop codon recognition (Figure 4) . Streptomycin, which also has substantial effects on tRNA selection, has no discernible effects on RF function on stop or near-stop codons (Figure 3) . Preliminary data consistent with the detailed analysis presented here were recently published in a symposium article .
The ribosomal and mRNA elements that are critical for stop codon recognition by release factors are therefore distinct from those required for codon recognition during EF-Tu-facilitated tRNA selection. Key nucleotides A1492, A1493, and G530, which undergo dramatic conformational rearrangements to form critical contacts in the minor groove of the codon:anticodon helix, are not important for stop codon recognition by release factors, nor are the 2 0 OH groups on the mRNA that interact with these critical rRNA nucleotides. Moreover, the disparate effects of paromomycin and streptomycin on RF function provide structural insight into RF-mediated stop codon recognition. Paromomycin binding directly displaces A1492 and A1493 from h44 into their extrahelical conformations Molecular Cell (Ogle et al., 2001) ; the extrahelical positioning of these nucleotides is thus thought to represent a productive state for tRNA selection. The competitive nature of paromomycin inhibition of RF-mediated stop codon recognition strongly argues that the productive state for peptide release places A1492 and A1493 in their h44-intrahelical positions. Streptomycin binds nearby at the junction of the small subunit shoulder with the h44 region and directly promotes the closure interactions that are required for tRNA selection Ogle et al., 2002) . The failure of streptomycin to affect peptide release at any codon tested argues that small subunit closure is not critical for peptide release. Thus, the molecular determinants for RF-mediated stop codon recognition are distinct from those utilized during tRNA selection.
Most importantly, the data presented here provide structural insight into the mechanism by which the specificity of peptide release is achieved. These insights come from the observation that certain perturbations of the decoding center have strikingly different effects on peptide release at stop and near-stop (sense) codons. First, while decoding center mutations (A1492, A1493, and G530 variants) have no effect on peptide release at stop codons, they result in substantial rate defects in peptide release at near-stop codons (generally 10-to 100-fold, with mutations at A1493 being the most deleterious) (Figure 1 ). In addition, although paromomycin negatively affects peptide release on both stop and near-stop codons, the kinetic mechanisms of this inhibition are distinct. The K 1/2 of RF1 for both stop and near-stop complexes is increased in the presence of paromomycin-the simplest explanation for this observation is competitive binding of the two molecules in the decoding center. However, on near-stop codons, addition of paromomycin results not only in substantial effects on the K 1/2 for RF binding, but also in substantial decreases in the k cat for peptide release (Figure 4) . These data are most easily explained by a model wherein stop codon recognition by RFs induces conformational rearrangements in the termination complex that are incompatible with continued binding to paromomycin. The correlated prediction would be that binding of RF to near-stop-codon complexes fails to induce these same conformational rearrangements, thus allowing for simultaneous binding of RF and paromomycin and ultimately resulting in effects on catalysis (k cat ) by the aminoglycoside (Figure 7 ). Chemical modification analysis was used to test these predictions by examining binding of paromomycin in the decoding center of stop and near-stop complexes in the presence of increasing amounts of RF. Indeed, paromomycin apparently remained bound to near-stop complexes even in the presence of kinetically saturating concentrations of RF, while addition of RF to authentic stop codon complexes resulted in the loss of paromomycin binding (Figure 6 ). A second binding site for paromomycin, located in the large ribosomal subunit near helix 69, was recently reported in a crystallographic study by Doudna Cate and colleagues (Borovinskaya et al., 2007) . That study argued that paromomycin binding to this helix 69 site is responsible for paromomycin-mediated inhibition of ribosome recycling through prevention of ribosome conformational rearrangements in intersubunit bridges (including helix 69) normally promoted by binding of ribosome recycling factor to posttermination complexes. Although we have not directly assessed the role of this binding site in paromomycin-mediated inhibition of peptide release, the inhibition we observe can readily be accounted for by the presence or absence of paromomycin in the decoding center.
We argue here that the structural rearrangement that occurs on stop codon recognition (which here results in paromomycin dissociation) is normally required for fast induction of catalysis of peptide release in the large subunit active site, and that the rate of peptide release on nearstop codons is impaired because the ribosome:RF complex does not efficiently rearrange to this maximally active state (Figure 7 ). Earlier studies in both bacteria and eukaryotes have provided indirect evidence that peptide release involves an initial codon-independent binding step followed by a rearrangement to a stop codon-specific state that is fully active for peptide release (Chavatte et al., 2003; Freistroffer et al., 2000; Yoshimura et al., 1999) . Our data are consistent with these ideas and provide insights into the nature of the rearrangements that may be required to reach the state maximally active for peptide release.
The increased sensitivity of peptide release to decoding center mutations at near-stop codons relative to stop codons ( Figure 5 ) is also consistent with this view. These data indicate that the mutations in the decoding center further impair the already hindered rearrangement to the active state on near-stop complexes. However, rearrangement upon RF recognition of stop codons is sufficiently robust to be insensitive to these mutations. The simultaneous presence of paromomycin and at least some decoding center mutations is then sufficiently inhibitory to cause k cat effects even on stop codons. The texture of these data is reminiscent of synthetic approaches used in a wide variety of systems to establish that events are associated with a common pathway (Duncan et al., 2007; Hartman et al., 2001) .
At a practical level, the data presented here provide evidence that the in vivo effects of aminoglycosides are likely to be manifested both on the process of tRNA selection (stimulatory) and on the process of peptide release (inhibitory). The in vivo efficacy of aminoglycoside therapy used to stimulate nonsense codon readthrough in prematurely truncated genes (Kaufman, 1999) likely benefits from both facets of drug action. While these ideas have previously been explored with reporter constructs in yeast (Salas-Marco and Bedwell, 2005) , the competitive nature of termination and near-cognate tRNA incorporation at nonsense codons makes the relative contribution of these two effects difficult to evaluate. The in vitro biochemistry performed here allows us to address these effects independently. Further experiments will be required to determine whether aminoglycosides also inhibit peptide release in eukaryotes, where the decoding center of the ribosome is conserved but release factor structure is distinct (Frolova et al., 1999) .
While we have little structural information about the rearrangement promoted during RF-mediated stop codon recognition, because it is incompatible with paromomycin binding it likely ends in a state where A1492 and A1493 adopt their intrahelical h44 positions. Given that conformational changes in the large ribosomal subunit active site must also occur for the hydrolysis reaction to proceed (Bieling et al., 2006; Brunelle et al., 2006; Schmeing et al., 2005) , and that the active site and decoding center are spanned by the release factor, one view is that stop codon recognition promotes structural rearrangements in the RF that then activate the large subunit peptidyl transferase center for catalysis. In fact, RFs can undergo large conformational rearrangements, although the physiological relevance of such large conformational changes is currently debated (Graille et al., 2005; Klaholz et al., 2003; Petry et al., 2005; Rawat et al., 2003; Vestergaard et al., 2005; Zoldak et al., 2007) . The rearrangement of the ribosomal decoding center seen here may indicate a role for the ribosome in promoting rearrangements in the release factor, or may simply be required for accommodating structural rearrangements in the RF. High-resolution structures of RFs bound to ribosome complexes containing stop and near-stop codons will be required to elucidate the specific interactions that facilitate this rearrangement, as has been done so beautifully for the case of tRNA selection (Ogle and Ramakrishnan, 2005) . Although such structural detail is currently lacking, our data argue that conformational rearrangements occur in response to RF recognition of stop codons, and further, that the accuracy of stop codon recognition, like the accuracy of tRNA selection (Gromadski and Rodnina, 2004a; Ogle and Ramakrishnan, 2005) , is driven by an induced-fit mechanism. The repeated use (A) When RF1 binds to ribosomes with a stop codon in the A site, a change in the conformation of the termination complex is induced that results ultimately in an ''induced'' ribosome state that is fully active for peptide release. This state includes a conformation of the decoding center that is not compatible with paromomycin binding. (B) When RF1 binds to ribosomes with a nearstop codon in the A site, it is unable to induce the conformational change that leads to fast peptide release. In the context of this ''uninduced'' decoding site conformation, paromomycin remains bound and further inhibits peptide release.
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of induced fit by the ribosome to control catalysis suggests a broad mechanism for regulation by a variety of extraribosomal factors.
EXPERIMENTAL PROCEDURES
Strains and Reagents Tight-couple 70S ribosomes from strain MRE600 were isolated from cells in exponential growth as previously described (Moazed and Noller, 1986 ) and stored in HiFi buffer (50 mM Tris-HCl [pH 7.5], 70 mM NH 4 Cl, 30 mM KCl, 3.5 mM MgCl 2 , 0.5 mM spermidine, 8 mM putrescine, and 2 mM DTT). Native IFs 1 and 3 and His-tagged IF2 were overexpressed and purified as described in decoding center nucleotides were expressed in strain DH5a from plasmid pSpurMS2 and isolated as described (Youngman and Green, 2005) . Initiation complexes containing mutant ribosomes were formed as above except that 1 mM purified 50S subunits from strain MRE600 (isolated as in Cochella and Green, [2005] ) were included during complex formation to replace 50S subunits lost during purification of mutant ribosomes. Release assays were performed in HiFi buffer at 37 C by mixing equal volumes of initiation complex and RF1. At appropriate time points, reactions were quenched with 25% formic acid and released f-[ 35 S]-Met was resolved from unreacted f-[ 35 S]-Met-tRNA fMet by electrophoretic TLC as described (Youngman et al., 2004) . Generally, initiation complexes were present at 0.25 mM in reactions. In cases where K 1/2 or IC 50 values less than 1 mM were being measured, initiation complexes were used at 10 nM in all reactions. For K 1/2 and IC 50 measurements, rate constants were measured at least in duplicate at a minimum of 8 concentrations of the reagent being titrated (either RF1 or paromomycin). Release reactions were carried out on ribosomes programmed with the stop codon UAA except in the case of assays involving tagged ribosomes, where UAG-programmed ribosomes were used to eliminate background from low levels of RF2 contamination in ribosome preparations. Peptidyl transfer reactions were performed as described (Cochella and Green, 2005) . For reactions containing antibiotics, initiation complexes formed as above were preincubated with paromomycin or streptomycin (Sigma-Aldrich) at twice the desired final concentration at 37 C for 2 min before being mixed with an equal volume of release factor or ternary complex.
DMS Footprinting and Primer Extension
Complexes for DMS modification were formed in DMS buffer (80 mM HEPES-KOH [pH 7.8], 10 mM MgCl 2 , and 100 mM NH 4 Cl) by incubating 1 mM 70S ribosomes, 1.5 mM tRNA fMet , and 3 mM mRNA for 30 min at 37 C. Twenty picomoles of ribosome complex were modified in each reaction. Stop codon complexes were diluted to 50 nM for modification; near-stop complexes were modified at 1 mM. Antibiotics were added for 2 min prior to incubation with RF1 for 5 min. DMS (SigmaAldrich) was diluted 1:12 in ethanol and added to complexes at a final concentration of 44 mM. Modification was carried out for 10 min at 37 C and stopped with 1 volume of DMS stop buffer (1 M Tris-HCl [pH 7.5] and 1 M bME). Modified complexes were ethanol precipitated and resuspended in RNAqueous lysis buffer, and RNA was extracted using the RNAqueous kit (Ambion). Primer extension was then carried out as described (Merryman and Noller, 1998 ) using a primer that begins extension at 16S rRNA nucleotide 1490. Quantitation was done using ImageQuant software. Normalization was performed by dividing A1408 intensity by the intensity of a constant band (arrowhead, Figures  6A and 6B ). To correct for the modest protection by RF1 seen in the absence of paromomycin, modification in the presence of paromomycin was then expressed as a fraction of the modification seen at the same concentration of RF1 in the absence of paromomycin. The RF1 concentration ranges used for both the stop and near-stop complexes were chosen to represent 0.625, 6.25, and 31.25 times the measured K 1/2 value at the chosen paromomycin concentration. Thus, the RF1 concentrations used in these experiments are similarly saturating for both codons tested. Additionally, extended incubation of near-stop paromomycin complexes with a high concentration of release factor gave no further loss of A1408 protection (data not shown).
